National settlement exceeding $80 million in nationwide class action involving claims for pesticide exposure against major international chemical company.
News
Verdict
January 11, 2015
Pendley, Baudin & Coffin has been involved in the GMO Rice litigation pending in St. Louis federal court since 2007 representing over 700 clients. The Multi District Litigation has settled for a cash payment for all claimants of $750,000,000 by A. G.
Verdict
October 07, 2014
Resolution of over 20,000 cases involving disputed sales taxes on manufactured homes. A settlement was reached in excess of $29 million.
Verdict
August 18, 2014
$10.3 million Settlement for Missouri residents who purchased Celexa or Lexapro for a minor child.
Verdict
August 04, 2014
Pendley, Baudin and Coffin helps to achieve $40 million class action settlement with GlaxoSmithKline. A federal judge in Minnesota approved the settlement to refund money to third party payors that paid for Paxil used by children.
Article
July 17, 2014
From: HarrisMartin's Drugs & Medical Devices Publication
Date: July 17, 2014
www.harrismartin.com
W. Va. Federal Judge Strikes Forest Labs' Learned Intermediary
Defense in Lexapro Suicide Case
WHEELING, W. Va. - A West Virginia federal judge has granted a plaintiff's motion to strike a drug maker's learned intermediary defense in a Lexapro suicide case, noting the state's high court has expressly declined to adopt the learned intermediary doctrine.
Article
May 23, 2014
On November 19, Johnson and Johnson announced a settlement of $2.5 billion to resolve the thousands of lawsuits over its recalled hip implants in an accord that may be worth more than $4 billion. There are about 12,000 suits filed in federal and state courts which face Johnson and Johnson and its unit DePuy.
Article
May 23, 2014
Pendley, Baudin and Coffin, L.L.P. has been the first law firm to file a Lipitor suit in Louisiana; the firm has also filed a suit in South Carolina.
Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company.
Article
May 15, 2014
Class Action Litigation Report
May 15, 2014
Pharmaceuticals
Hundreds of Women Sue Pfizer; Failure to Warn of Diabetes Risk Alleged
By Julie A. Steinberg